<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Alsaidalani AA</submitter><funding>Instituto de Salud Carlos III</funding><funding>European Society for Immunodeficiencies</funding><funding>Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases</funding><funding>NIAID NIH HHS</funding><funding>Comunidad de Madrid</funding><funding>NCI NIH HHS</funding><funding>Fundación para la Investigación del Hospital Universitari La Fe</funding><pagination>13</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10966939</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>44(1)</volume><pubmed_abstract>Human BCL10 deficiency causes combined immunodeficiency with bone marrow transplantation as its only curative option. To date, there are four homozygous mutations described in the literature that were identified in four unrelated patients. Here, we describe a fifth patient with a novel mutation and summarize what we have learned about BCL10 deficiency. Due to the severity of the disease, accurate knowledge of its clinical and immunological characteristics is instrumental for early diagnosis and adequate clinical management of the patients.</pubmed_abstract><journal>Journal of clinical immunology</journal><pubmed_title>Inherited Human BCL10 Deficiencies.</pubmed_title><pmcid>PMC10966939</pmcid><funding_grant_id>#1R01CA269217-01A1</funding_grant_id><funding_grant_id>PI22/00790</funding_grant_id><funding_grant_id>R01 CA269217</funding_grant_id><funding_grant_id>PI17/00543</funding_grant_id><funding_grant_id>R21AI171466</funding_grant_id><funding_grant_id>1R01AI168210-01A1</funding_grant_id><funding_grant_id>PEJD2019-PRE/BMD-16556</funding_grant_id><funding_grant_id>R01 AI168210</funding_grant_id><funding_grant_id>Ayudas Luis _Alvarez 2022 FIBHULP</funding_grant_id><funding_grant_id>ESID Bridge Fellowship</funding_grant_id><funding_grant_id>R21 AI171466</funding_grant_id><pubmed_authors>Bukhari E</pubmed_authors><pubmed_authors>Lopez-Lera A</pubmed_authors><pubmed_authors>Lopez-Collazo E</pubmed_authors><pubmed_authors>Martinez-Barricarte R</pubmed_authors><pubmed_authors>Sanchez-Ramon S</pubmed_authors><pubmed_authors>Corvillo F</pubmed_authors><pubmed_authors>Van Den Rym A</pubmed_authors><pubmed_authors>de Andres A</pubmed_authors><pubmed_authors>Garcia-Solis B</pubmed_authors><pubmed_authors>Alsaidalani AA</pubmed_authors><pubmed_authors>Perez de Diego R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inherited Human BCL10 Deficiencies.</name><description>Human BCL10 deficiency causes combined immunodeficiency with bone marrow transplantation as its only curative option. To date, there are four homozygous mutations described in the literature that were identified in four unrelated patients. Here, we describe a fifth patient with a novel mutation and summarize what we have learned about BCL10 deficiency. Due to the severity of the disease, accurate knowledge of its clinical and immunological characteristics is instrumental for early diagnosis and adequate clinical management of the patients.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Dec</publication><modification>2025-04-04T21:45:31.116Z</modification><creation>2025-04-04T21:45:31.116Z</creation></dates><accession>S-EPMC10966939</accession><cross_references><pubmed>38129623</pubmed><doi>10.1007/s10875-023-01619-z</doi></cross_references></HashMap>